Please login to the form below

Not currently logged in
Email:
Password:

Par elects new chairman

US generic drug manufacturer Par Pharmaceutical has elected president and CEO Patrick G LePore as chairman of the board of directors.

US generic drug manufacturer Par Pharmaceutical has elected president and CEO Patrick G LePore as chairman of the board of directors.

LePore, who joined Par's board in May 2006, has been president and CEO since September 2006.

LePore replaces John D Abernathy as chairman. Abernathy will remain a board member.

Joseph E Smith, a member of the board since 2004, has been named lead director. Prior to his retirement in 1997, he held leadership positions with Warner-Lambert.

On 9 August, Par's shares fell USD 0.73, or 3.5 per cent, to USD 20.03 in pm trading. Shares have traded between USD 15.50 and USD 30.68 over the past year.

10th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics